Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
2.
Chemotherapy ; 49(6): 269-79, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14671426

ABSTRACT

In the present review article, the penetration of antimicrobial agents into prostatic fluid and tissue was examined. Three major factors determining the diffusion and concentration of antimicrobial agents in prostatic fluid and tissue are the lipid solubility, dissociation constant (pKa) and protein binding. The normal pH of human prostatic fluid is 6.5-6.7, and it increases in chronic prostatitis, ranging from 7.0 to 8.3. A greater concentration of antimicrobial agents in the prostatic fluid occurs in the presence of a pH gradient across the membrane separating plasma from prostatic fluid. Of the available antimicrobial agents, beta-lactam drugs have a low pKa and poor lipid solubility, and thus penetrate poorly into prostatic fluid, expect for some cephalosporins, which achieve greater than or equal to the inhibitory concentration. Good to excellent penetration into prostatic fluid and tissue has been demonstrated with many antimicrobial agents, including tobramycin, netilmicin, tetracyclines, macrolides, quinolones, sulfonamides and nitrofurantoin.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Prostate/chemistry , Prostatitis/drug therapy , Humans , Hydrogen-Ion Concentration , Male
3.
In Vivo ; 17(2): 151-2, 2003.
Article in English | MEDLINE | ID: mdl-12792976

ABSTRACT

A 73-year-old woman was admitted to hospital with a one-month history of temporal headache, low-grade fever, fatigue, nocturnal sweats and pleural pain. On the fifth day after admission she developed chest pain at the left site of the thorax, productive cough and progressive dyspnea. A pleural effusion was revealed on physical examination, as well as a bilateral temporal artery thickening. An erythrocyte sedimentation rate of 135 mm in the 1st hour was found. Chest X-ray showed left pleural effusion. Thoracocentesis revealed serous fluid exudate. A percutaneous pleural biopsy showed only minimal inflammatory changes. Temporal artery biopsy showed giant cell arteritis. The patient received prednisone 60 mg/daily with a dramatic clinical response. Pleural effusion is a rare manifestation of temporal arteritis; only seven cases have been reported worldwide. We present a new case of temporal arteritis with pleurisy.


Subject(s)
Giant Cell Arteritis/pathology , Pleural Effusion/pathology , Pleurisy/pathology , Aged , Anti-Inflammatory Agents/therapeutic use , Diagnosis, Differential , Female , Giant Cell Arteritis/complications , Giant Cell Arteritis/drug therapy , Humans , Pleural Effusion/etiology , Pleurisy/etiology , Prednisone/therapeutic use , Radiography, Thoracic , Treatment Outcome
4.
In Vivo ; 17(1): 51-3, 2003.
Article in English | MEDLINE | ID: mdl-12655790

ABSTRACT

A 43-year-old Greek cattler with a history of brucellosis three months previously for which he was treated with sulfonamides for three weeks, was admitted to the hospital complaining of fever, arthralgias, night sweats, painful cervical and axillary lymph nodes as well as a weight loss of 8 kg in the previous four months. Since microbiological and serological studies did not give a specific diagnosis, an open cervical lymph node biopsy was performed. The histological examination revealed Kikuchi-Fujimoto disease. The etiology of the disease is unknown but viral, bacterial, protozoal and neoplastic as well as physicochemical agents may stimulate a particular immune response leading to Kikuchi-Fujimoto disease. Hereby, we present a case in which Kikuchi-Fujimoto disease followed brucella melitensis infection. This association permits us to hypothesize that the initial brucella melitensis infection three months previously triggered an immune response leading to Kikuchi-Fujimoto disease. The association of the disease with brucellosis is very important since these two entities share some similar characteristics, with brucellosis being relatively common in Europe. To our best knowledge, in the English language bibliography, this is the first reported case worldwide, though another similar case was described in the Spanish literature ten years ago.


Subject(s)
Brucella melitensis/immunology , Brucellosis/complications , Brucellosis/immunology , Histiocytic Necrotizing Lymphadenitis/immunology , Histiocytic Necrotizing Lymphadenitis/microbiology , Adult , Brucellosis/pathology , Histiocytic Necrotizing Lymphadenitis/pathology , Humans , Lymph Nodes/microbiology , Lymph Nodes/pathology , Male
5.
In Vivo ; 16(1): 73-6, 2002.
Article in English | MEDLINE | ID: mdl-11980366

ABSTRACT

A 64 year-old Caucasian female of Greek origin was admitted to hospital with painful cervical and axillary lymphodenitis accompanied by fever and night sweats for 10 days. The patient had undergone a pacemaker implantation six weeks before disease onset because of heart conduction abnormalities. A diagnosis of Kikuchi-Fujimoto disease was established after lymph node biopsy. The etiology of the disease is unknown but viral, bacterial, protozoal; and neoplastic as well as physicochemical agents may stimulate a particular immune response. Hereby, we hypothesize that the implant pacemaker can act as a physicochemical agent triggering Kikuchi-Fujimoto disease. We present this case and we discuss various disease aspects. A brief review of the literature is also given.


Subject(s)
Histiocytic Necrotizing Lymphadenitis/etiology , Pacemaker, Artificial/adverse effects , Postoperative Complications , Female , Histiocytic Necrotizing Lymphadenitis/pathology , Humans , Lymph Nodes/pathology , Middle Aged
6.
Anticancer Res ; 22(6B): 3801-4, 2002.
Article in English | MEDLINE | ID: mdl-12552997

ABSTRACT

N-acetyltransferase-2 (NAT-2) and Glutathione-S-transferase M1 and T1 (GSTM1 and GSTT1) polymorphism have been implicated in the detoxification of urothelial carcinogens, such as arylamines and polycyclic aromatic hydrocarbons. The results of epidemiological studies examining the role of NAT-2, GSTM1 and GSTT1 genotypes on the risk factors for bladder cancer were controversial, although suggesting that there may be an increased risk of the disease associated with these genotypes. The aim of the present study was to examine the independent effect and a possible interaction of NAT-2, GSTM1 and GSTT1 genotypes on the risk of bladder carcinogenesis, in the frame of a case-control study. We also investigated the possible association of specific genotype combinations with more aggressive disease in terms of tumor grading and local staging at the time of initial diagnosis. Between August 1996 and May 1998, 89 newly-diagnosed bladder cancer patients (transitional cell type) and 147 controls were included in the study. All patients were selected at the time of first diagnosis, done in the Department of Urology at the University Hospital of Ioannina, in north-western Greece. GSTM1 and NAT-2 deficient genotypes were found to be independently associated with the risk of bladder cancer (odds ratios 2.87 and 2.64, respectively). The GSTT1 genotype did not present any significant association with bladder cancer risk. We did not find a significant interaction between genotypes. These results could be explained by the independent activity of the two enzymes. Studies that will simultaneously examine the role of several genetic and environmental factors involved in bladder carcinogenesis are needed to give a global picture for the risk factors of bladder cancer and their potential interaction.


Subject(s)
Arylamine N-Acetyltransferase/genetics , Carcinoma, Transitional Cell/enzymology , Glutathione Transferase/genetics , Urinary Bladder Neoplasms/enzymology , Aged , Arylamine N-Acetyltransferase/metabolism , Carcinoma, Transitional Cell/genetics , Carcinoma, Transitional Cell/pathology , Case-Control Studies , Female , Genotype , Glutathione Transferase/metabolism , Humans , Male , Middle Aged , Neoplasm Invasiveness , Neoplasm Staging , Risk Factors , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...